Voxzogo: A white to yellow lyophilized powder
Vosoritide is a human C-type natriuretic peptide (CNP) analog. Vosoritide is a 39 amino acid peptide. Its amino acid sequence includes the 37 C terminal amino acids of the human CNP53 sequence plus Pro Gly on the N terminus to convey resistance to neutral endopeptidase (NEP) degradation. Vosoritide is manufactured from Escherichia coli using recombinant DNA technology. The FDA approved this drug in 2021 to increase linear growth in pediatric patients with achondroplasia who are 5 years of age and older with open epiphyses. This medicine comes in the form of single-dose vials in 0.4 mg, 0.56 mg, or 1.2 mg to administer subcutaneously. The recommended dosage of Voxzogo is based on the patient’s actual body weight.
The medicine Voxzogo is an Achondroplasia treatment in India, and it is readily available from multiple certified medicine suppliers. To know more about this medicine, contact us on toll-free no. 18008891064.